# ClosedLoop.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/closedloop-ai

- Industry: Software
- Headquarters: Austin, US
- Website: www.closedloop.ai
- Total disclosed funding: $45M
- Latest round: Series B (Aug 17, 2021)
- Investors on record: 8

## About

ClosedLoop.ai Inc. is a US-based company specializing in healthcare data science, focused on enhancing patient outcomes and reducing costs through advanced predictive analytics and artificial intelligence applications.ClosedLoop.ai Inc. was founded in 2017 in Austin, US, by Andrew Eye and Dave DeCaprio. The company has successfully raised USD 34.00 mn in its Series B funding round on August 17, 2021, led by Titanium Ventures, with participation from investors such as Breyer Capital and HealthFirst Financial, LLC. ClosedLoop has executed a total of 3 deals since its inception.ClosedLoop offers a comprehensive platform designed to improve healthcare outcomes and lower costs through predictive analytics. Its key products include a suite of tools that enable healthcare organizations to harness artificial intelligence and machine learning for data analysis. The company's initial product, Healthy, is a conversational AI application that allows users to monitor their health through personalized interactions, targeting various healthcare markets including systems, ACOs, and insurers in the United States.The company generates revenue through partnerships and subscription models with healthcare organizations, engaging clients through annual or multi-year contracts that provide access to predictive modeling tools and extensive support services. Revenue is derived from structured pricing plans tailored to meet the specific needs of diverse organizations, ensuring that ClosedLoop can deliver valuable insights into patient care and operational efficiency.ClosedLoop.ai plans to leverage its recent funding of USD 34.00 mn raised in August 2021 to enhance its technology and expand into new markets. The company aims to develop upcoming products that further utilize AI and machine learning in healthcare analytics. Specific geographic regions targeted for expansion have not been detailed, but the strategic growth focuses on enhancing the platform's capabilities and reaching a broader client base.

## Funding rounds

- Series B, Aug 17, 2021, $34M — Greycroft, .406 Ventures, Titanium Ventures, Breyer Capital, Gaingels, HealthFirst Financial, LLC
- Series A, Nov 19, 2020, $11M — Greycroft, .406 Ventures, Silicon Valley Bank, Meridian Street Capital

## Investors

- Greycroft (https://capitalatlas.ai/funds/greycroft) — Series A, Series B
- .406 Ventures (https://capitalatlas.ai/funds/406-ventures) — Series A, Series B
- Silicon Valley Bank — Series A
- Meridian Street Capital (https://capitalatlas.ai/funds/meridian-street-capital) — Series A
- Titanium Ventures (https://capitalatlas.ai/funds/titanium-ventures) — Series B
- Breyer Capital (https://capitalatlas.ai/funds/breyer-capital) — Series B
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B
- HealthFirst Financial, LLC — Series B